Life Sciences
Technology
SaaS Finance
Sustainable + Renewable
Special Situations
Select Page
Life Sciences
Technology
SaaS Finance
Sustainable + Renewable
Special Situations
About
Meet our team
Investor Relations
Portfolio
Podcast
Careers
Giving Back
Press Releases
Contact Us
×
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Executive Team
Annual Reports & Proxy
Contacts
FAQ
ESG
Financial Info
Overview
Financial Results
Credit Ratings
Stock Data
Overview
Quote
Charts
Historical Data
Analyst Coverage
Distributions
Tax Information
Distributions Reinvestment Program
Insider Ownership
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Policy
Filing Type:
View All
10-K
10-K/A
10-Q
144
25
25-NSE
3
4
4/A
40-17G
40-APP
40-APP/A
424B2
424B3
424B5
497
497AD
5
8-A12B
8-A12G
8-K
8-K/A
ABS-15G
APP NTC
APP ORDR
ARS
CERT
CERTNYS
CORRESP
DEF 14A
DEFA14A
DFAN14A
EFFECT
FWP
N-2
N-2/A
N-23C-2
N-2ASR
N-2MEF
N-54A
NT 10-K
POS 8C
POS EX
PRE 14A
PREC14A
REGDEX
RW
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
Date
Form
Description
PDF
XBRL
Pages
02/18/04
REGDEX
Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]
5
rss_feed
Filing RSS
arrow_back
1…
233
234
235
236
237
238
239
240
241
242
Email Alerts
Contacts
RSS News Feed